Position history for Candriam S.C.A.'s holdings in VERTEX PHARMACEUTICALS INC
Candriam S.C.A. holds 228,915 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $102.2M as of 2026-Q1. The position was increased (+1.6% shares). VRTX represents 0.5% of Candriam S.C.A.'s portfolio.
Current Value
$102.2M
Current Shares
228,915
Total Value Change
-$51.6M
Total Shares Change
-99,356
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 228,915 |
+1.6% |
| $102.2M |
| 0.5% |
| $474.27 |
43 |
| 2025-Q4 | Increased | 225,292 | +29.1% | $102.1M | 0.5% | $453.74 | 53 |
| 2025-Q3 | Decreased | 174,567 | -1.0% | $68.4M | 0.4% | $395.31 | 0 |
| 2025-Q2 | Decreased | 176,398 | -11.0% | $78.5M | 0.5% | $441.30 | 0 |
| 2025-Q1 | Decreased | 198,287 | -23.3% | $96.1M | 0.6% | $492.69 | 0 |
| 2024-Q4 | Decreased | 258,622 | -16.9% | $104.1M | 0.6% | $399.35 | 0 |
| 2024-Q3 | Decreased | 311,307 | -5.2% | $144.8M | 0.8% | $462.88 | 0 |
| 2024-Q2 | Decreased | 328,271 | -15.5% | $153.9M | 0.9% | $468.72 | 0 |